Pfizer Inc. (NYSE: PFE) reported third quarter 2022 earnings results today. Revenues decreased 6% year-over-year to $22.6 billion. Reported net income increased 6% YoY to $8.6 billion, or $1.51 per share. Adjusted EPS rose 40% to $1.78. Both revenue and earnings beat estimates. The company raised the lower end of its full-year 2022 revenue guidance […]
Pfizer Inc. (NYSE: PFE) reported third quarter 2022 earnings results today. Revenues decreased 6% year-over-year to $22.6 billion. Reported net income increased 6% YoY to $8.6 billion, or $1.51 per share. Adjusted EPS rose 40% to $1.78. Both revenue and earnings beat estimates. The company raised the lower end of its full-year 2022 revenue guidance […]
Pfizer Inc. (NYSE: PFE) reported third quarter 2022 earnings results today.
Revenues decreased 6% year-over-year to $22.6 billion.
Reported net income increased 6% YoY to $8.6 billion, or $1.51 per share. Adjusted EPS rose 40% to $1.78.
Both revenue and earnings beat estimates.
The company raised the lower end of its full-year 2022 revenue guidance to a range of $99.5-102.0 billion. It also revised its FY2022 adjusted EPS guidance from $6.30-6.45 to a range of $6.40-6.50.
